Ribociclib 200mg Film-Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer With Proven Overall Survival Benefit Across Pre/Perimenopausal and Postmenopausal Women
Palbociclib 75mg, 100mg, 125mg Capsules — First-in-Class CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer in Combination With Endocrine Therapy
